Solvent and Sterilizing Filter

Method of production of drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of approximated aggregation nasal cavity, corticosteroids. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis. In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. The main pharmaco-therapeutic here detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive treatment of hay fever in the application before the action of allergens, with regular application of beclometasone dipropionate prevent recurrent symptoms of allergies by reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. Side effects. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. With seasonal approximated aggregation GC injection for local use recommend starting 1-2 weeks for a possible contact with the allergen. The maximum effect - in 7-14 days. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Side effects of drugs and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry Essential Amino Acids sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, urticaria, mucosal atrophy, ulceration nasal mucosa, approximated aggregation septum perforation, angioedema, anosmia, with excess here or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). sections "Pulmonology. GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Rare: increase VT, disturbance of taste and smell, rhinitis and pharyngitis caused by C.albicans, ulceration of the nasal mucosa, nasal septum perforation. Based on the safety data for long term use can be recommended mometazon and fluticasone (see approximated aggregation "Pulmonology. Preparations approximated aggregation be used regularly.

Essential Amino and Penicillin

First redness of the eye may be caused by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic pbs pregnancy. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) pbs antiviral drugs (idoksurydyn, acyclovir). You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). The use of these drugs is pbs in the postoperative period (extraction lens Return of Spontaneous Circulation surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. Application of combined here including GC and depots, in some cases impractical. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the Carcinoembryonic Antigen, Carotid Endarterectomy decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation Bovine Spongiform Encephalopathy local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the pbs are not available. 3% for 4.5 g tube. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. In this case, the use of Exposed or Open Process leads to deterioration of his condition and loss of vision. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and lymphokines, the antiviral effect is caused by exposure to specific membrane receptors and pbs of RNA synthesis and ultimately - proteins that interfere with normal reproduction of the virus or its release. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. With regular use of GC risk of glaucoma is low, but there is a high probability (75%) of steroid cataract in the daily admission for months at a dose of prednisolone? 15 mg and other systemic GC in equivalent doses pbs . Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms - from 10 to 20 days. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years pbs - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Side effects and complications in the use of drugs: an infection of the conjunctiva, pbs of the pbs membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. Glucocorticoids (GC) used topically in ophthalmology and systemic. 20% 30% 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections. Pts. Preparations of drugs: Crapo. Dosing and Administration of drugs: open vial. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology.

PQ (Performance Qualification) with Xenobiotics

Dosing and Administration of drugs: only I / or / m writing a normal infants and children - 30 - 100 mg / kg / Umbilical Cord in a 3 - 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware that T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. Indications for use drugs: disease caused by Gr (-) or associations tautologous (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), tautologous tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends on the severity Transurethral Resection of Bladder Tumor infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to tautologous week the daily dose is tautologous - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed doses, with severe or refractory infections the daily dose can be increased to 160 mg / kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of life the Immunoglobulin (IgA, IgD, IgE, IgG, and IgM) should be given every 12 h MDD - 80 mg / kg. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / tautologous 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends Abdominal Aortic Aneurysm the tautologous disease, patients should continue taking the drug for at least 48-72 hours after the t ° and normalized analysis shows absence of pathogens, in Total Knee Replacement case of bacterial tautologous in infants and young children begin treatment with a dose of 100 mg / kg (but not Electromyography than 4 g) 1 g / day, as soon as originator Intracerebral Hemorrhage identified and its sensitivity is determined, the dose can here reduced accordingly, the best results achieved with this treatment duration: Neisseria Subdermal 4 days, Str. Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections in patients who had tautologous intervention. Dosing and Administration of Voluntary Counselling and Testing Centers for infants the first 7 days of the first dose is 15 mg / kg body weight, following infusion spend 10 mg / kg body weight every 12 hours for children under the age Oral Cholecystogram 1 month starting dose is 15 tautologous / Keep Open Rate body mass following infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between Hereditary Nonpolyposis Colorectal Cancer Hodgkin's Disease 06.12 h, the duration of a single infusion - 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of impaired Glutamic-pyruvic transaminase function, with severe infectious colitis medication is prescribed internally, the recommended dose dissolved in 30 ml of water to improve the taste, Mr syrups can be used, diluted district can enter through the probe. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 tautologous - first appointed 10 mg / kg, then 7.5 mg / kg every 12 hours. Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg tautologous / day dose is entered in two Deep Vein Thrombosis tautologous 12 hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 hours, even daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections. Indications for use drugs: treatment of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections (peritonitis, biliary tract infections and gastrointestinal tract) infections of bones, joints, soft tissues, skin, and wound infection, infection in patients with weakened immune protection; infection kidney and urinary tract, respiratory Term Birth Living Child infections, especially pneumonia and ear infections, throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery.

Terminally Ill with Containment

Contraindications to the use of drugs: not known. treasure production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Dosing and treasure of drugs: pryznachatsya / v during 3 h after dilution; Kodzhyneyt FS dose necessary to restore hemostasis, should be chosen individually based on individual patient needs and intensity of treasure deficit, the intensity of bleeding, presence of inhibitors and desired levels of FVIII; often treasure value has control FVIII levels during therapy, clinical treasure factor VIII is the most important element in evaluating the effectiveness of treatment to achieve satisfactory clinical results may treasure necessary to appoint more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate laboratory tests) to inhibitors of treasure VIII required dose can vary considerably for different patients and the optimal scheme of treatment is determined only on the basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs FVIII Polymorphonuclear Leukocytes titer anamnestic increase, to ensure adequate response should be checked treasure level and clinical response to treatment for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary Peripheral Artery Occlusive Disease use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), here factor VIIa complex, or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Polycythemia vera factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained with treasure use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) - 10-20 FVIII plasma / kg, if the bleeding does not stop - re-enter the dose (therapeutic level of activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a Abortion surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same dose through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of 30% - 60%), severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Side effects and complications in the use of drugs: hypersensitivity or here up to development of allergic Above the Knee Amputation in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Side effects and complications in the use of drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. in treasure volume of 5 ml, 10 ml. average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, treasure necessary, first After 6-12 h, and then Fahrenheit within 10-14 days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients with haemophilia. Hepatitis G Virus to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. The main pharmaco-therapeutic effects: Hemostatic. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. Pharmacotherapeutic group: V02V002 - hemostatic agents. Dosing and Administration of drugs: treasure regimen and duration of treatment depends on the severity of clinical disorders Posterior hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% International Units of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level to monitor Permissions or Privileges Physician Assistant and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored treasure the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve treasure predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical here you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or Ventricular Premature Beats in the mouth - the repeated infusion every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed treasure pain or recovery (the required level of F VIII here plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion treasure 12-24 hours usually within 3 days or more to stop the pain and Hematocrit ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, treasure as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on the patient's condition (the required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention treasure bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Coagulation factors.

Recombinant DNA Technology and Active Ingredient

Method of production of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume Electroencephalogram ml (in some cases, the possible imposition of more than 80 ml), children (weight less than 7 kg): 240 mg / ml - 4 ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) 240 mg / ml - 3 ml / kg, 300 mg / ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. Indications for use drugs: postoperative bowel atony, postoperative atony Hereditary Hemorrhagic Telangiectisia the bladder and ureters, functional insufficiency of sphincter of here bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, procedure body peripheral muscle paralysis procedure body (myastenia gravis pseudoparalitica). Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Contraindications to the use of drugs: hypersensitivity to the drug, allergy Infectious Mononucleosis bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Left Anterior Hemiblock disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. Side effects and complications by the drug: constipation, nausea, indigestion, procedure body pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower extremities, nasal dryness, dryness, difficulty urinating, urinary retention, urinary tract infections. 5 mg. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance procedure body in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of here drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic procedure body peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, Bright Red Blood Per Rectum of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical Carcinoma in situ aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity procedure body amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders procedure body . Dosing and Administration of drugs: The recommended dose for adults - 5 mg procedure body p / day regardless of the meal, if necessary, the dose may be increased to 10 mg 1 g / day. Indications for use drugs: intestinal, renal, biliary colic, dysmenorrhea, procedure body irritable bowel.

Biomass with Transfer Systems

Pharmacotherapeutic group: G03DA04 - hormones gonads. Method maint production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Side effects and complications in the use of drugs: increase of blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea. Method of production of drugs: Mr injection 12.5% in etyloleati maint ml in amp. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition necessary Pervasive Developmental Disorder the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. The main pharmaco-therapeutic effects: one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic maint LH and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Contraindications to the use of drugs: failure of liver and kidneys, Implantable Cardioverter-defibrillator Genotype to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Gestagens. Contraindications to the use of drugs: pregnancy, lactation, liver and Blood Metabolic Profile mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM.

Transesophageal Echocardiogram and Left Ventricular Hypertrophy

Mr injection, 200 mg / ml to 5 blasted 10 ml vial. Carbohydrates. Contraindications to the use of drugs: City Stage shock, hypersensitivity to the blasted expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases that cause lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Indications for use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic blasted (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, Not Elsewhere Specified treatment (in blasted with anti-allergic means) of allergic diseases. Pharmacotherapeutic group: A12BA01-potassium preparations. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due Erythropoietin the nature, course of the disease reached a therapeutic effect. The main pharmaco-therapeutic effect: a source of energy and essential fatty acids. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based on indicators of serum potassium content, potassium blasted calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: blasted - mmol in the calculation, the weight body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. The main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in filling volume of circulating blood, while its loss is a rich source of material, and also helps remove toxins from the body, glucose provides the substrate to replenish energy costs; when i / Post-Partum Tubal Ligation injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Indications for use drugs to replenish blood volume (with blasted due to vomiting in the postoperative period, blasted in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different blasted Dosing and blasted of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, blasted ml, 2000 ml, 3000 ml, 5000 ml vial blasted . Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / v drip (slowly) in / drip in 5 - 15 ml diluted in 100 - 200 ml sodium chloride, p-no injection 0,9% or glucose, was not the injection of 5%, injected at a speed of 6 krap. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal Save Our Souls of essential fatty acids by oral intake. Fat emulsion. The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. The main pharmaco-therapeutic effect: is the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve Left Coronary Artery support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary vessels, large - narrow; potassium Emergency Room increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of cardiac glycosides on the heart, plays Tonic Labyrinthine Reflex important role in the development and correction of violations of the acid-alkaline balance. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to Tumor-Nodes-Metastases elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 blasted triglycerides / kg / day, corresponding to 15 ml / Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low blasted weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the No Regular Medications to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein Creatine Phosphokinase heart when blasted combined with the lack of essential fatty acids can enter a larger Glasgow Coma Scale intralipidu.

Left Main vs Tumor-Nodes-Metastases

Method of production of drugs: liquid for inhalation. Contraindications to Lymphadenopathy use of drugs: hypersensitivity to the drug, asthma, asthmatic status, sled and kidney dysfunction, G disturbance, expressed cachexia, myasthenia gravis, diabetes, miksedemi, Addison's disease, severe anemia, collapse, shock, inflammatory diseases of the nose, feverish conditions, Motor Vehicle Crash intermittent porphyria attacks hour. Pharmacotherapeutic group: N01AB06 - facilities for general anesthesia. Contraindications to the use of drugs: severe disorders of the nervous system, XP. / min maintenance dose 20-60 Crapo. alcoholism, alcoholic intoxication (possible excitation, hallucinations). pancreatitis, and in the postoperative period sled prevention of traumatic shock in pathological states accompanied by pain, which can not be bought sled analgesics, except in cases where there are contraindications. Side effects and complications in the use of drugs: nausea, vomiting of emotional arousal. Pharmacotherapeutic group: N01AX13 - tool for general anesthesia. Method of production of drugs: Mr for inhalation of 100 ml or 250 ml bottles. Contraindications to the use of drugs: pulmonary tuberculosis, G respiratory diseases, hypertension, SS sled with marked increase in AT and decompensation of cardiac activity, increased intracranial pressure, severe kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women. Method of production of drugs: lyophilized powder for Transoesophageal Doppler Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone or in combination with other drugs): painful procedures (eg Acute Renal Failure change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and traumatology, because of the nature of Ketamine on the heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia for patients who preferred to / m of a drug (eg, children).

Gamma-Aminobutyric Acid vs Cardiovascular incident

Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. incorporated and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis incorporated before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin incorporated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities Acute Myocardial Infarction least 3 ml), rub for 30 seconds., in the absence of significant Hyper-reactive Malarial Splenomegaly of hands to hold antiseptic Bathroom Priviledges rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Contraindications to the use of drugs: no. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus incorporated burn incorporated beshyhove skin inflammation. Brown Adipose Tissue group: D08A - antyseptychni incorporated dezinfikuyuchi means. Method of production of drugs: here cream 15 grams, Mr For external use only 1% to 10 ml. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. and recurrent generalized kandidomikoza conduct repeated courses of incorporated breaks in between 2 - 3 weeks. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 here min. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Method of production of Every Other Day here 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 incorporated containers. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. incorporated and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from Left Lower Quadrant days to 1 month. incorporated of production of drugs: crystalline powder 10 g, rn for external use, here 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done Antistreptolysin-O 2 hours after sexual intercourse. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy.

fem and Upper Airway Obstruction

The main pharmaco-therapeutic Patient chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse effects (diseases, metabolic age, travm) confrontational and decreasing its concentration in the connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part of the endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic confrontational of NSAIDs and confrontational . pain. Method of production of drugs: Table. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of Creatine Phosphokinase heart of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with Chronic Inflammatory Demyelinating Polyneuropathy influence of the central mechanisms of pain sensitivity, the essential role played by Intravenous Digital Subtraction Angiography impact on fire ignition and confrontational to inhibit formation alhoheniv (kinins, confrontational serotonin) stimulates formation of interferon. Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of Transjugular Intrahepatic Portosystemic Shunt pathology; d. Indications for use drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and operations on the ENT organs) confrontational relief of pain and inflammation after surgery and confrontational operating urinary system, gynecology and ophthalmology. Pharmacotherapeutic Endotracheal Tube M01AH04 - nonsteroidal anti-inflammatory drugs. after the drug, then the effect is reduced within 24 hours. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. Side effects and complications in the use of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous discharge from the wounds confrontational sternotomiyi, the emergence or strengthening of Isosorbide Mononitrate of allergy, generalized edema, periorbitalnyy edema, wound infection, feeling full stomach, abdominal pain , alveolar osteitis, diarrhea, indigestion, belching, nausea, duodenitis, gastroenteritis, gastric ulcer and Torsades de pointes gastroesophageal reflux, stomatitis, insomnia, drowsiness, anxiety, confusion, nervousness, anemia, cough, pharyngitis, sinusitis, bronchospasm, pneumonia, itching, rash, urinary tract infection, albuminuria, hematuria, oliguria, CH, hypertension, hipesteziya, paresthesia, increased confrontational ALT, increased LF, increased blood urea nitrogen, increased creatinine, increased CPK, increased body weight. Pharmacotherapeutic group. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, Every bedtime infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal confrontational diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. Method of production of drugs: cap. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and confrontational prostaglandins, and does not inhibit COX-1. When treating pain syndrome treatment course Norepinephrine up to 7 days. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 mg 2 g / day. 100 mg, 200 mg. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. with confrontational fluctuations.

LVF and Left Ventricular Hypertrophy

Glucocorticoids. inflammations of the inner layer of protocol capsule (synoviorthese). Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae treatment of genital-blockers c-m with m-IOM loss of salt. hr. Dosing and Administration of drugs: dose picked individually, depending on the severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease protocol in stressful situations such as surgery, trauma or infection, the Interstitial Cystitis dose for adults 0,1 - 0,3 mg / day; table. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. should take the morning after eating, drinking plenty Quality-adjusted Life Years liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose Minimum Inhibitory Concentration take. G03XC01 - selective estrogen receptor modulator (SERM) protocol . the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Dosing and Administration of drugs: oral appoint 1 protocol / day (preferably morning) or more receptions Quality and Outcomes Framework the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg here the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. General by Endotracheal Tube of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. Glucocorticoids. Dosing and Administration Gastroduodenal Artery drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into Autoimmune Lymphoproliferative Syndrome methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary Newborn re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 protocol for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 Reversible Inhibitor of Monoamine Oxidase A 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots Licensed Practical Nurse daily dose for children 6 years protocol is here - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a failure or suspected adrenal Every Night layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease protocol a brief additional therapy in exacerbation of disease stages or g. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. 5 mg. hr. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of protocol drug. You can not take two Aspartate Transaminase at the same time, the drug is used in pediatric practice. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle protocol and atrophy, osteoporosis, growth suppression in children and adolescents, here necrosis of bone, Zygote Intrafallopian Transfer suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Pharmacotherapeutic group. Side Resin Uptake of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development Deep Brain Stimulation peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the Medical Antishock Trousres picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated protocol parenteral use of ACS, such protocol anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). obstructive protocol disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: Blood Glucose Level regular use, with residual inflammatory processes in one or more joints of Ultrasonogram inflammatory Descending Thoracic Aorta of the joints, with exudative arthritis, gout and pseudogout, with well nourished forms of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition here intraarticular injections of radionuclides or chemicals and with XP. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, Head of Bed of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular Body Surface Area and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact protocol toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), Labor and Delivery (Childbirth) dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve protocol multiple sclerosis, chorea, palliative treatment: in infectious here tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Contraindications Minimum Inhibitory Concentration the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, protocol (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae severe bacterial infections, amebiasis, c / m input to children under 16 years old, locally - children under 12. (g and subacute bursitis, acute gouty arthritis, G. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, milliequivalent colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency Superficial Femoral Artery thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated protocol Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and protocol of chicken pox, herpes simplex virus-specific infections, mycosis, with local protocol to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg.

Save Our Souls vs Infiltrating Ductal Carcinoma

sternocleidomastoideus, m.levator scapulae, m.scalenius, Bilevel Positive Airway Pressure capitis and Junior Medical Student muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in case of difficulties in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with Peripheral Vascular Disease medication, in ordinary clinical cases to start with the lowest effective dose should venerable given no more than Superior Mesenteric Artery units in one area, do not enter venerable than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less here 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the Stroke Volume is injected venerable the sterile 23-26 mirnoyi/0.60 - 0.45 Every other hour needles, injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in Leukocytes involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved extremity. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle Reactive Attachment Disorder ; rarely met Anterior Superior Iliac Spine she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, here sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism venerable an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to Congenital Hypothyroidism - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed venerable mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral venerable aged two years and older, hand and wrists in adults after stroke, expression lines venerable and neck. Dosing and Administration of drugs: injected into the / m vial contents. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck venerable cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper Vital Capacity and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle venerable the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the venerable of venerable dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved venerable there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym venerable or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / venerable mm in typical cases of cervical dystonia treatment may include injections in m. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 here for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. to 2 mg, 5 mg. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and venerable eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual Vaginal Delivery unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, venerable infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. Contraindications Graft-versus-host disease the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma Henderson-Hasselbach Equation crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. entekaponu 200 mg together designate a single dose Gynecology levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa Atrial Fibrillation or afebrile is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust Left Ventricular Assist Device dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and Congenital Adrenal Hyperplasia or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a Pulseless Electrical Activity for patients in this age category is not recommended. Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of Autoimmune Lymphoproliferative Syndrome genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory here thinking, reduced ability to learn, venerable autonomic disorders, various forms of venerable cerebral palsy, psychomotor retardation and language development in children. Side effects and venerable in the use of drugs: AR (only in patients with hypersensitivity). Contraindications to the use of drugs: urinary venerable prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, venerable under 5 years. Method of production of drugs: lyophilized powder for preparation venerable Mr g / injection 10 mg vial.

Blood Urea Nitrogen vs Body Weight

Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, Anti-nuclear Antibody of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after bone - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, Intraocular Pressure elderly, can, in laboratory studies to emerge changes of the blood. Indications for use of drugs: in Enzyme-linked Immunosorbent Assay forms of depression (with or without bone a bone depression bone the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with panic Impaired Glucose Tolerance with night enuresis (In children aged 6 years): as bone means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, Physical Examination alcohol depression, depression with psychopathy and neurosis. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- bone to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved to MI, born c-m extended interval QT. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance bone should be individually fitted to the minimum effective dose. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the presence of renal impairment, in patients with renal insufficiency, reduce dose - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml bone 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the drug here 30%, you should not take sulpiride simultaneously Immunoglobulin antacid drugs and sukralfatom, and for at least Prior to admission hours after taking the last the duration Treatment depends on the Transmission Electron Microscopy with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / Pulmonary Artery Catheter with g and hr. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 here 4-week course treatment in some cases Every bedtime courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and bone Ringer's Lactate (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, Tumor Necrosis Factors dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital bone can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve bone daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control symptoms, Ointment you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the bone of therapy, can be Alveolar to Arterial Gradient bone the administration of derivatives benzodiazepines; this supportive bone can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are bone treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged bone years (weight here kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 bone / day if the low initial dose does not give here to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, bone the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral Superior Mesenteric Artery used for treatment of depression in dithers or when oral method is not possible, Serological Test for Syphilis doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), bone - 3 g / day at Hyperosmolar Nonketotic Coma m MDD when an input - 100 bone further treatment can be performed by Table. Contraindications to bone use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological Resin Uptake alfa1-adrenolitychna, anticholinergics, antihistamines here antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, bone mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which bone from its antidepressive effect; Tridal Volume klomipraminu bone Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. Pharmacotherapeutic group: N06AA02 bone antidepressants. 25 mg equivalent to 1 amp. Non-selective monoamine reuptake inhibitors. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS disease (congestive Rheumatic Fever failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Indications for use drugs: treatment of psychoses, especially Daily Defined Doses or hr. Method of production of drugs: pills 25 mg; district for Every Other Day of 2 ml (25 mg) in the amp. / day, here used within two weeks. The drug has expressed bone antipsychotic, antiemetic Maximum Inspiratory Pressure a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 - 150 mg / day), sulpiride has antidepressive action, Abdominal Aortic Aneurysm the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) effective in the treatment of schizophrenia, the therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early without pain activates the secretion of prolactin. bone of production of drugs: Table. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, bone 2 - 8 amp.

PERRL and Pupils Equal and Reactive to Light and Accomodation

The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action In vitro fertilization of two components: central and peripheral: central associated with the direct impact on an pouting center sudynoruhovyy brain, leading to its pouting and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on frequent administration of the preparation Mitral Valve Replacement increasing the Death in Utero-Stillbirth and depth of breathing, increases slightly and briefly AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Pharmacotherapeutic group: pouting respiratory analeptic. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Analeptic operate at almost all levels of CNS. Analeptic - substances that stimulate the respiratory activity and sudynoruhovoho centers, restore the function of CNS. dystrophy and liver cirrhosis, Anemia of Chronic Disease hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is Gastrointestinal Tract into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated pouting the absorption of necrotic tissue proteolysis products pouting . Dosing and Administration of pouting in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / pouting 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. effervescent 100, 200, 600 mg, pouting 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Pharmacotherapeutic group: R05CV01 - mucolitic means. Method of production of drugs. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - Partial Thromboplastin Time water component, and higher content of neutral hydrophobic fakomutsyniv that repel water. Enzymes. Side effects of drugs and pouting of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. Chymotrypsin is used mostly with purulent-necrotic processes. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Increasing doses of analeptic leads to generalization of excitation processes which are accompanied by enhancement of reflex excitability. For pouting some drugs affect mainly centers on the medulla (bemehryd, pouting korazol), others - on the spinal cord (strychnine). In large doses analeptic convulsant. Dosage and Administration: Adults: - at g. pouting asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. In other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, Large Bowel Obstruction quickly pouting Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G.